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ABSTRACT

HEMODYNAMIC AND METABOLIC ASSESSMENT OF
CANINE HEARTS
PRESERVATION

ISOLATED

FOLLOWING TWENTY-FOUR HOUR
IN

INTRACELLULAR-TYPE

Steven

Brent

1988

Slovic

FLUID

I.ABSTRACT

A Langendorf preparation with a
was used to evaluate the

left ventricular balloon

isovolumetric

function of six dog

hearts before and after twenty-four hour preservation in a
four-degree Celsius bath of intracellular-type
Each heart served as

its own control

fluid(ICF).

and cross-perfusion from

a support dog was used during hemodynamic assessment of the
isolated hearts.
(LVPD),

Mean left ventricular pressure development

left ventricular positive dp/dt

(LV dp/dt)

diastolic compliance were measured at baseline
and again 0.5,

1.0,

2.0,

and 3.0 hours

oxygen and lactate content were measured
and coronary sinus blood.

was determined prior to storage and

(pre-storage)

following twenty-four

hour preservation and blood reperfusion.

arterial

and

At each time point
in samples of

Gravimetric water content
following three hours of

reperfusion.
All

six hearts beat upon blood reperfusion and showed

preserved contractile and metabolic

function.

The average

LVPD and LV dp/dt reached baseline after two hours of
reperfusion.

The diastolic compliance after preservation

(0.50

± 0.26 mmHg),

(1.90

-

0.26 mmHg),

was significantly decreased

from baseline

but did not change during the three-hour

V

period of blood reperfusion.
ventricular tissue

increased

The water content of the
from 78.7 ±

freshly excised hearts to 82.1
four hour storage and 3

+

0.3 ml/lOOgm

left
for

0.4 ml/lOOgm after twenty-

hours of blood reperfusion

(P<0.05).

Oxygen consumption and lactate extraction after preservation
were not significantly different
We conclude that:
the simple technique of

1)

from baseline values.

Twenty-four hour preservation by

immersion in cold,

intracellular-type

fluid effectively preserves hemodynamic

function as

manifested in both pressure development

(LVPD)

"contractility"
depressed

(LV dp/dt);

2)

Hemodynamic

and

function

is

initially after twenty-four hour preservation and

subsequently improves progressively with blood reperfusion,
reaching pre-preservation levels after three hours;
recovery of hemodynamic

The

function occurs despite decreased

diastolic compliance and the presence of myocardial
and 4)

3)

Recovery of hemodynamic

edema;

function corresponds with the

return of metabolic function towards baseline.
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II.

INTRODUCTION
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II.

A.

INTRODUCTION

The Shortage of Donor Hearts
This past December 2nd marked the twentieth anniversary

of the

first human heart transplant by Dr.

in South Africa.

Today heart transplantation

therapeutic technique
disease partly

Christiaan Bernard
is a real

for patients with end-stage heart

due to the

1980 to combat rejection;

introduction of cyclosporine
In 1986 more than 2000 heart

transplants were performed worldwide and

it

is predicted that

about 4000 will have been performed in 1987(64).
experienced centers report actuarial
80% and 100% at one year and 50%
compare

favorably to 42%

at

survival

one-year survival

The most

rates between

five years.

need of organs but denied eligibility.

These rates

for patients

Furthermore,

Stanford's heart transplant recipients who have
year have been able to return to normal
activity

in

5%

in
of

lived one

occupation and

(67).

Despite such clinical
treating rejection,

success and the

improvements

cardiac transplantation is still

in

faced by

a major barrier—the ever present lack of donor organs!
estimated 14,000 people could benefit
every year in the United States
them

(approximately one of

(20)

An

from a heart transplant
and at least 1000 of

four patients actually on a
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waiting list)
(13,83).

may die before a donor heart becomes available

Thanks

in part to media coverage,

awareness of the need
Nonetheless,

for donor organs has

the supply of donor hearts

further reduced by the

is

organs

increased.
likely to be even

introduction of seatbelt laws,

requiring the use of child-restraint seats,
motorcycle helmet laws

the public

(21).

The

handgun laws,

and

fear of transplanting

infected by Human Immunodeficiency Virus

(HIV)

likely to eliminate more potential donor organs
consideration

laws

is also

from

in the coming years.

Several years ago the use of cardiac xenografts
taken from another animal
availability of donors.

species)
However,

(hearts

promised to provide easy
graft survival

in animal

testing has been poor and xenografting cannot be considered a
viable alternative until
ibility is overcome

the major problem of histoincompat-

(52,84).

The questions of public

acceptability and the possibility that animal

organs may

harbor infectious agents that may be transmitted to the human
recipient must also be considered.
The advent of the Jarvik artificial heart

in 1982

also

failed to eliminate the shortage of donor hearts and
introduced other ethical

and technical problems.

Cardiac

support by a mechanical device

is currently a viable option

for individuals whose clinical

condition deteriorates while

awaiting a human heart.

However,

as

transplantable human hearts exists,
artificial hearts as

long as the shortage of
the use of temporary

"bridges" to a human heart cannot

4

increase the total number of human lives saved by heart
transplants

(1).

Patients with artifical devices are given

higher priority than patients being medically managed while
awaiting a donor heart,

thereby only changing the identity of

the people who obtain the available human hearts.
Since cardiac transplantation is not likely to be
superseded soon by xenografting or artificial devices,
donor-shortage problem will

need to be resolved

if

develop fully as a therapeutic clinical procedure.

it

the
is to

Extending

the effective period of storage of hearts will be one way to
increase the donor pool;
will

Long-term

(twenty-four hour)

storage

allow truely remote harvesting—essentially from all

regions of the world— enabling the use of organs that would
otherwise be

"wasted".

A recent retrospective review of 233

potential

cardiac

donors referred over six years to the University of Arizona
Health Sciences Center showed that the

largest category

of all donor refusals consisted of 50 patients,
acceptable,

(31%)

otherwise

who were refused as cardiac donors because an

ABO-compatible recipient was not readily available

(18).

This suggests that long-term storage will not only allow time
for more

in-depth histocompatability matching,

but would also

effectively expand the donor pool by providing time to
distribute organs to ABO-compatible recipients.
The current method of heart procurement

in most active

transplant centers utilizes storage of the donor hearts
bucket

filled with sterile saline at

in a

four degrees Celsius.

5

Experimental

and clinical

studies have shown that good

protection achieved

in this manner is

hours

The present study evaluates the use of an

(4,8,14,57).

intracellular-type

limited to four to six

fluid that mimicks the normal

ion

composition of

fluid in cells

for long-term myocardial

preservation.

Its design was based on established principles

of myocardial protection and the experiences of other
investigators

in the

field of organ preservation.
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B.

Principles of Myocardial Protection
A heart may suffer ischemic damage during harvesting

from the donor or during the operation to transplant
the recipient.

However,

quantified the decrement

it

into

Burt and Copeland recently
in

function of rabbit hearts at each

step in the transplantation process and

found that the

greatest damage occurs during the period of cold storage(11).
The challenge to protect the heart during this time of cold
ischemia

is similar to the problem encountered during cardiac

surgical procedures such as coronary artery bypass grafting
and valvular replacement.

Ideally the solutions used

for

cardioplegic protection during clinical open-heart surgery or
for organ storage should:

1)

provide

immediate pharmacologic

arrest to lower energy demands and avoid energy depletion by
ischemic electromechanical work;
energy demands

2)

use hypothermia to reduce

further and prevent recurrence of

electromechanical activity;

3)

provide substrates

continued aerobic or anaerobic activity;

and 4)

for

prevent or

reduce unfavorable interstitial and cellular changes such as
edema(9).
Potassium has been the mainstay of almost all
cardioplegic and organ-preservation solutions since solutions
containing high potassium concentrations were
1955 to facilitate cardiac surgery(45,55).

first used in

Extracellular

7

hyperkalemia provides

immediate cardiac arrest by

depolarizing cell membranes and produces a state of sustained
diastole.

The blockade of contractile activity minimizes

oxygen demand and eliminates ATP-expending actin-myosin
interaction.

The safe upper limit of potassium concentration

remains unclear.

However,

Tyers et al.

found that

functional

deterioration equivalent to that seen with sixty minutes of
normothermic

ischemic arrest resulted only when hyperkalemia

twenty-five times
heart

(about

in excess of that required to arrest the

10 mEq/L)

Hypothermia

was used(76).

is also used in organ protection to reduce

energy requirements and oxygen demand.

The question of the

optimal temperature to achieve maximal protection cannot be
unequivocally answered from the available data.
Griepp and their colleagues demonstrated

Angell

and

in two separate

studies with canine hearts that the duration of allowable
ischemia

is a linear function of the logarithm of

temperature(2,31).
using

These studies and another by Tyers et al.

isolated rat hearts

Henseleit

(75)

found that saline or Krebs-

(extracellular-ion composition)

buffers at ten to

fifteen degrees Celsius gave better functional
preservation for relatively short-term(one to
cardiac

and metabolic
four hour)

ischemia than four degree or twenty degree Celsius

solutions.

In contrast,

hearts preserved at

Swanson et al.

four degrees Celsius

observed that canine
for five hours

functioned at levels equal to or greater than hearts stored
at

fifteen degrees Celsium and they found no evidence of

8

myocardial damage attributable to the cooler temperature
alone(71).
The studies mentioned above were
temperatures approaching
periods,

in agreement that

zero degrees,

had a deleterious effect.

even

for short

Although red blood cells

and bone marrow are successfully preserved by

freezing,

only

limited success has been achieved using cryopreservation of
hearts.

Offerijns and Krijnen found that good preservation

of rat hearts

in a supercooled state

(-18 degrees Celsius)

for longer periods than one or two hours was
though dimethyl

sulfoxide

cryoprotectant(60).

(DMSO)

Likewise,

freezing of puppy hearts at -2
irreversible

impossible even

was employed as a

Bausamian et al.

found that

degrees Celsius produced

injury precluding resuscitation(3).

However,

using a combination of mechanical dehydration and glycerol
saturation,

the same group successfully transplanted several

puppy hearts that had been cooled to -8 degrees Celsius
several hours without freezing.

Therefore,

investigators concluded that it
and thawing,

is the

not cooling per se,

that

for

these

insult of

freezing

irreversibly damages

hearts.
The relative importance of hypothermia and potassiumbased chemical cardioplegia
been studied.

in myocardial protection has also

It appears clear that they have separate and

additive properties(34,72).
Details of the molecular mechanisms
injury are presently unknown.

involved

in tissue

Purported mechanisms

include

9

depletion of the cellular high-energy phosphate supply,
accumulation of toxic waste products,
transmembrane
swelling

(37) .

and alteration of

ionic gradients with resultant cellular
Effective hypothermia and cardioplegic arrest

appear to preserve cytosolic adenosine triphosphate
levels well

(25,42).

It has also been well

(ATP)

established that

the cellular swelling that characterizes both ischemia and
hypothermia can be greatly reduced by making preservative
solutions hyperosmolar by the addition of solutes such as
glucose or mannitol

(27,28,49).

steroids and phenothiazines as

Other compounds,

including

"membrane-stabilizers",

been used in attempts to aid myocardial protection.

have

In fact,

so many agents were being tested that Katz was prompted to
calculate that about a million experiments could be done to
characterize the interactions and effects of just thirty
cardioplegic solutions(39)!

In the discussion that

follows,

some of the most promising and more recent approaches to the
problem of long-term cardiac preservation will be reviewed.
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C.

Techniques of Long-Term Preservation
The

first successful

attempt to maintain hearts outside

of the body for more than a
Lindbergh,

few hours

is attributed to

who in 1935 used a self-contained,

perfusion apparatus(51).
popular technique
In 1969

In vitro perfusion has remained a

for long-term preservation of the heart.

Feemster et al.

used hyperbaric,

perfusion at twenty-four degrees Celsius
fibrillating heart)
(24).

pulsatile

pulsatile

(with a continuously

to attempt long-term cardiac preservation

Many other workers have used continuous,

hypothermic
success.

(four to ten degrees Celsius)

This technique

low-pressure,

perfusion with more

is thought to provide a continual

supply of oxygen and substrates as well as removal of waste
products.

Proctor and Parker introduced low-pressure

perfusion in 1968 and preserved dog hearts
return of "strong contractions",
observation,

for 72 hours with

as judged by gross

upon blood reperfusion(63).

In the early 1970s,

several groups of investigators demonstrated survival
animals

of

following orthotopic transplantation with grafts

preserved for 24

to 28 hours using this technique(17,62,74).

Trunkey et al.(1970)

used oxygenated,

filtered canine plasma

and mimicked contractions with external compression by a
silastic balloon to perfuse hearts without edema.
hearts preserved

Eight

in this manner for twenty-four hours

initially functioned well

after orthotopic transplantation,
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but began to fail after four hours(74).
transplanted sixteen hearts

Proctor et al.(1971)

following 72 hours of perfusion

with Krebs crystalloid with survival
maximum of fourteen hours(62).

in ten animals up to a

Copeland et al.(1973)

also

used hypothermic perfusion with a modified Krebs solution,
along with pretreatment of the donor animal with
phenoxybenzamine and glyceryl trinitrate.

An overall

rate of 30% was achieved at twenty-four hours

following

orthotopic transplantation of the preserved hearts
Encouraged by these earlier reports,
al.(1981)

surival

(17).

Guerraty et

performed a similar study using canine hearts

preserved twenty-four hours with continuous hypothermic
perfusion with modified Krebs solution.

However,

the

addition of post-operative

immunosuppression to their

protocol

to 73%

improved survival

at one day following

orthotopic transplantation and a 20%
achieved at thirty days post-op(32).
al.(1984)

stored hearts

survival

rate was

In addition,

Miller et

for twenty-four hours with continuous

perfusion with oxygenated Krebs at five degrees Celsius and
compared this method of preservation to simple-storage
perfused)

in a

(non-

five-degree bath of Ringer's lactate.

Ventricular pressure development and positive dp/dt were
measured following orthotopic transplantation.

The

ventricular function of the hearts preserved by perfusion was
virtually identical to control,
open-chest dogs.

untransplanted hearts

in

The hearts stored in the cold bath of

Ringer's lactate showed depressed function,

60% to 80%

of
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control values(57).
Wicomb and his colleagues

in South Africa used this

technique to perfuse baboon hearts

for twenty-four hours and

after orthotopic transplantation achieved consistent survival
until

rejection(16,81).

experimental

laboratory,

Following this success
Wicomb et al.(1984)

only clinical use to-date of hearts
preservation.

in the

reported the

following long-term

Four patients underwent heterotopic

transplantation with donor hearts preserved from seven to
seventeen hours by continuous perfusion with oxygenated,
hyperosmolar,

standard cardioplegia.

Three of the

four donor

hearts required considerable support by the recipient
circulation and inotropes

for up to twenty-four hours post-op

and in two cases the donor hearts would not have supported
the circulation initially

if orthotopic transplantation had

been performed.

All

normal

although one

function,

four hearts subsequently recovered
failed shortly secondary to

acute rejection(80).
Despite the attention that perfusion techniques have
received,

it is apparent that perfusion per se

absolutely essential

is not

for successful preservation.

The choice

of storage solution also seems to play a significant role
determining the outcome of organ storage.
described shortly,

intracellular-type

very successfully both to perfuse

Furthermore,

As will be

fluids have been used

isolated hearts

continuously for twenty-four hours and
perfused storage.

in

for simple,

non-

orthotopic transplantation is
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not the only way in which cardiac
following preservation.
Bethencourt(7)

perfused with cold,
respectively.

Like the present study,

and Levitsky(50)

balloons to study the

function has been assessed

used

intraventricular

function of isolated canine hearts

modified Krebs solution and canine plasma

A comparison of ventricular function curves

for the preserved hearts versus a group of control hearts
demonstrated that good preservation was achieved.
In the

future,

prove beneficial
ischemia time.

several relatively new approaches may

in prolonging the viable hypothermic
Fluosol

DA,

a perfluorochemical with a very

high oxygen-carrying capacity
a myocardial protectant
scavengers,
the

is being used experimentally as

(19,35,38,43).

such as superoxide dismutase,

seem to prevent

injury caused by oxygen free radical generation during

blood reperfusion of stored organs(69).
high

Free radical

Constant-strength,

intensity magnetic fields have also been found to reduce

mitochondrial

injury in preserved hearts(29).
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C.

The Use of Intracellular-Type Fluid

(ICF)

for Organ

Preservation

Theoretical value of ICF.

Biopsies of

ischemic

myocardium show that hypothermia and standard cardioplegia
are able to maintain high levels of cytosolic ATP.

However,

immediately upon reperfusion with warm blood and the onset of
contractions,

there

is a rapid fall

in ATP.

ATP levels may

reach or fall below the association constant of critical
enzymes such as the sodium-potassium ATPase and the sodiumcalcium ATPase

(25).

This loss of ATP is most likely

associated with its utilization to restore transmembrane
ionic gradients that were disrupted by ischemia and
hypothermia.

Although hypothermia reduces energy

requirements and ATP expenditure by slowing metabolic
processes,

it directly suppresses the ATPase sytem that

normally regulates

ion distribution across cellular

membranes—i.e.

ATPase suppression results

magnesium loss,

and sodium and chloride gain by the cell(54).

The increase in intracellular osmotic
draws water into the cells.

in potassium and

force passively

The resultant cellular swelling

may obstruct small vessels and worsen the actual
tissue damage(48).
levels

fall,

readily.

In addition,

as

ischemic

intracellular potassium

extracellular calcium enters the cell more

Suppression of the normal ATP-dependent sodium-

calcium exchange mechanism by cold and/or ischemia or due to
a relative deficiency of ATP following

reperfusion allows
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intracellular calcium to rise to high levels.
myocardial contracture such as

is seen with

Eventually

"stone hearts"

or

"reperfusion injury" may result(9,26).
Unlike standard,
saline,
type

Krebs'

solution,

fluid(IGF)

stored organs.

or Ringers lactate,

in ATP levels and ion distribution in

ICF mimicks the normal composition of

fluid

especially the high potassium and low sodium

concentrations,

causing ions to equilibrate across cellular

membranes at intracellular concentrations.
cold storage in ICF,
levels will

intracellular-

is thought to prevent or reduce such

detrimental changes

within cells,

extracellular-type media such as

Therefore,

during

intracellular potassium and sodium

in theory remain unchanged.

Normal

gradients and effective electromechanical

transmembrane

function will be

readily reestablished upon blood reperfusion.

In this way,

the use of ICF eliminates the considerable ATP expenditure
which would be needed to regenerate transmembrane

ionic

gradients and diminishes cellular swelling and calcium uptake
and the resultant sequelae

(9,30).

The Use of ICF for Kidney and Lung Preservation.

The

use of ICF for enhancement of hypothermic organ preservation
was

first described by Keeler et al.

(40).

over twenty years ago

Subsequent studies by Collins(1969)

and Sacks(1973)

convincingly demonstrated the effectiveness of simple bathing
in cold ICF to preserve canine kidneys
(15,66).

for 30 to 72 hours

These studies again demonstrated the clear benefit

of pharmacologic preservation

in addition to the protection
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afforded by hypothermia alone.

Collins'

and Sacks'

solutions

are still used clinically and make international exchange of
renal allografts possible.

These solutions are also

currently used in clinical lung transplantation,

since the

only satisfactory results in lung preservation have been
obtained with intracellular-type solutions
ICF and Cardiac Preservation.

(33,59,73).

Clinical use of ICF for

human heart transplantation has not yet been attempted.
However,

a number of investigators have studied

intracellular-type fluids for preservation of animal hearts.
Kohno et al.(1987)

preserved isolated rat hearts for four

hours at zero degrees Celsius in a bath of Collins'

solution

and compared the myocardial cation contents during storage
and reperfusion to those in hearts stored in a standard,
potassium-high sodium,

cardioplegia.

low

ICF indeed prevented

myocardial sodium accumulation and potassium depletion during
storage and myocardial sodium and calcium overload after
reperfusion compared with the standard cardioplegia

(41).

This study supports the theory that the benefits of ICF are
not solely due to potassium-induced diastolic arrest of the
heart.
Feeley et al.(1986)

also used Collins'

short-term canine heart preservation.

solution for

This group attempted

en bloc heart-lung storage for five hours in a four-degree
Celsius bath of Collins'

solution.

After combined heart-lung

transplantation recipient dogs succumbed secondary to
pulmonary edema,

but cardiac function was adequately

17

preserved.

The cardiac output was also better in

transplanted animals

following Collins'-storage than after

storage with standard cardioplegia

(23).

Other investigators have used ICF for intermediatelength

(eight to fourteen hours)

variable success.

In 1972,

rat hearts with Collins'
fourteen hours.

cardiac preservation with

Caiman and Bell perfused

solution at

isolated

five-degrees Celsius

for

The hearts were evaluated after

reestablishing circulation by connecting them to the aorta
and vena cava of an intact
"viable",

"recipient"

rat.

To be scored as

electrocardiographic evidence of electrical

activity was necessary and the heart had to beat continuously
for at least ten minutes
perfused with Collins'
(<10%)

following reperfusion.

Hearts

solution had very poor viability

in comparison to hearts perfused with standard

cardioplegic solutions containing insulin,
phenoxybenzamine

15% dextran-40 and

(12).

As part of their study to define the limits of
hypothermic preservation,
canine hearts

in a bath of

solution for twelve hours.

Griepp et al.(1974)

stored

five

four-degree Celsius Collins's
Post-storage

function was

assessed by orthotopic transplantation with an average
survival of 21 hours,
(31).

reflecting "borderline organ viability"

Sewell et al.(1978)

achieved much better results by

using immunosuppression to evaluate chronic animal
following orthotopic transplantation.

survival

Six canine hearts were

transplanted after eight hours of simple refrigeration at

18

eight-degrees Celsius

in Collins'

solution.

All

six

recipient dogs survived the perioperative period although
atrial pacing and dilute norepinephrine and dopamine drips
were required for the

initial

six to twelve hours.

died secondary to non-cardiac causes within the

Two dogs

first month.

The other four dogs survived and underwent cardiac
catheterization at one month post-op which demonstrated
normal

filling pressures,

output

(68).

ejection

fraction,

and cardiac

Twenty-Four Hour Cardiac Preservation with ICF.

Tables

1 and 2 present the composition and experimental design of
the previous studies which have used
fluids

for long-term

(24 hour)

intracellular-type

preservation of canine hearts.
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Studv

Bayliss
(1970)

Solution
(approx.
"Fluid
composition II"
**
(g/L)
30
Sodium
130
Potassium
Calcium
0.1
2
Magnesium
Chloride
30.1
Phosphate
100
2
Sulfate
Bicarbonate 130
Glucose(g/L) —
Dextrose(g/L) 10
Dextrose-40
40
(g/L)
Insulin(u/L) 20
Methylpred.
125
(mg/L)
Heparin(u/L) 20k
Mannitol(g/L)—
Fluorocarbon —
ATP-MgC12
5%

Reitz*
(1974)

Thomas*
(1975)

Watson*
(1977)

16
130

16
117

16
117

16
16
120

16
16
120

16
16
100

20
—

20
—

20
20

60
15
100
60
20
20

60
15
100
60
20
20

50

50

25

25

25

15
130
-3
15
160
3
20
20
—

25
10%
40

—

lOcc
4

4

4

4

Oxvoenation

No

No

No

No

No

Osmolaritv
(mOsm/L)

354

330

430

430

460480

Table 1.

10
115
1.0
6
15
95
6
10
14

—

( m/L)
Lidocaine —

Temperature
0
(deg. Celsius)

Present
Study (ms)

modified
Collins'

C
S
S
C=Collins'
S=Sacks'
—=unnamed
10
14
14
126
115
126
30
15
100
30
10
25

Suzuki
(1984)

3

3

Yes

Yes

460

460

4

No
410

Composition of Intracellular-type Solutions used for
24-Hour Cardiac Preservation.
*Investigators using two intracellular-type solutions
**mEq/L except where otherwise specified

4

No
480
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Bayliss
(1970)

Studv:

10

N=

Reitz
(1974)

Thomas
(1975)

11/7

12/15

Storage
Method:

simple
bath

simple
bath

simple
bath

Storage
Time:

24 hrs.

18-26
hrs.

24

Assessment:

gross,
ECG

ortho.
tx.

hetero.
tx., ECG

Temp.
(degrees
Celsius)

Table 2:

0

4

hrs.

4

Watson
(1977)

6/6

Present
(1988)

5

a)perfused
b)simple
bath
24

Suzuki
(1984)

hrs.

ortho.
tx.

3

6

perfused

24

hrs.

LV balloon
ortho, tx.

4

•
•

Design of 24-Hour Preservation Studies Using ICF

simpl
bath

24

hrs

LV
ball.

4
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Bayliss and Maloney(1970)

were the

to use ICF for cardiac storage.
hearts

first

investigators

They placed ten canine

in a bath of ICF and a second group of control hearts

was stored in Normosol
twenty-four hours at

(extracellullar-type solution)

zero degrees Celsius.

for

The hearts stored

in Normosol did not regain an effective beat upon blood
reperfusion from a support dog.

In contrast,

hearts stored in ICF "beat vigorously"

all ten of the

and regained

electrical activity for the full three-hour evaluation period
following reperfusion(6).
Reitz et al.(1974)

also reported effective twenty-four

hour preservation of canine hearts using a simple hypothermic
bath of ICF.
Collins'

Reitz evaluated eleven hearts stored

solution and seven more stored in Sacks'

orthotopic transplantation.

As evident

solution has approximately the same
composition as Collins'
with mannitol.

All

solution,

in table

in
solution by

1,

Sacks'

intracellular ion

but

is made hyperosomolar

eighteen hearts were easily defibrillated

upon reperfusion with warm blood and supported the
circulation once weaned off of cardiopulmonary bypass
although eleven required a continuous

isoproterenol

infusion.

Fourteen out of the eighteen recipient animals were weaned
from the ventilator and lived eight hours to five and onehalf days with

four surviving until

rejection.

three hearts stored similarly in Krebs'

Only one of

solution could be

defibrillated and it did not support the circulation
Thomas et al.(1975)

confirmed Reitz's

(65).

findings with
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Sacks

'

solution

(about 25%

survival to rejection)

and also

described a new solution with even higher osmolarity that
yielded a 93% survival

rate.

The viability of preserved

hearts was assessed by gross observation,
pressure measurements,

ventricular

and electrocardiographic tracings

following heterotopic transplantation into the neck of
recipient dogs.
of Sacks'
hours.
until

Twelve hearts were stored in a simple bath

solution at

four-degrees Celsius

for twenty-four

All were resuscitated but only three
rejection at five to twenty-six days.

fifteen hearts

(93%)

stored

in Thomas'

new,

(25%)

Fourteeen of the
hyperosmolar

solution survived beyond six days to rejection
fifty-seven days)
Watson(1977)

survived

(range six to

(72).
performed the next studies of cardiac

preservation with ICF.

He compared simple refrigeration to

continuous perfusion using foxhound hearts and orthotopic
transplantation.

Six donor hearts were perfused

continuously at three-degrees Celsius
with oxygenated ICF.
bath of cold,

for twenty-four hours

Six other hearts were suspended

oxygenated ICF.

Of the twelve donors,

in a
six

perfused and four nonperfused grafts survived the twenty-four
hour post-transplant period.
within two hours after weaning
intractable tachyarrythmias.

Two nonperfused grafts died
from bypass secondary to
More severe damage was also

noted on gross examination of the nonperfused hearts although
they had an average weight loss of 5%

in contrast to the 34%

average weight gain of the perfused hearts

(78).
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In a separate study using the same
solution,

intracellular-type

Watson and his colleagues compared continuous to

intermittent perfusion for 48-hour preservation.

Seventeen

foxhound hearts were perfused continuously with oxygenated
ICF for 48 hours at three-degrees Celsius.
stored for 48 hours using

15 minute cycles of oxygenated

perfusion and non-perfusion.
transplantation,
and four(24%)

all

Six others were

six(100%)

Following orthotopic
of the

intermittently perfused

of the continuously perfused hearts survived

the 24-hour postoperative period.

Several

of the recipient

animals required ventricular pacing and all
continuously supported by dopamine
postoperatively.

of them were

infusions and ventilated

The dogs were sacrificed 24 hours after

transplantation and there was a significant weight gain
both sets of hearts;

58%

for intermittently-perfused and 86%

for the continuously-perfused hearts
The only other,

and most recent,

24-hour preservation was performed
al.(1984).

Five

for

(79).
evaluation of

ICF

in Japan by Suzuki

for

et

isolated canine hearts were refrigerated at

four-degrees Celsius while a modified Collins'
perfused retrogradely

solution was

into the the coronary sinus.

ventricular balloon was used to study the hearts

A left

following

storage and three of them were also assessed by orthotopic
transplantation.
all

There was no weight change

in the hearts,

five had normal end-systolic pressure-volume ratios,

and

the three transplanted hearts supported the circulation for a

few hours postoperatively.
pursued(70).

Long-term survival was not
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E.

Experimental Design

The present study was undertaken to reevaluate simple,
hypothermic,

twenty-four hour storage with a

intracellular-type solution.

Previous

fundamental

investigators have

judged the success of ICF-preservation by subjective,
observation or by orthotopic transplantation.
survival

gross

Although

of the animal with the orthotopically transplanted

heart is a practical endpoint,

survival as an "all-or-none"

phenomenon does not adequately quantitate graft
Therefore,

function.

a particular objective of this study was to

perform precise assessment of hemodynamic and metabolic
parameters of ventricular function.
To accomplish this we chose the technique developed by
Opie and Gorlin for isolated rat hearts

(22,61)

and

subsequently modified by Holdefer and Edwards(36)
hearts.

An intraventricular balloon was placed

Langendorf preparation(46)

for canine

into a basic

which uses a non-working,

isolated

heart supported by retrograde coronary perfusion from a
support animal.

This model

allows heart rate and preload to

be controlled while another determinant of mechanical
performance,

the

inotropic state

the advantage of perfusing the

is evaluated.

It also has

isolated hearts with a

biologic medium at the appropriate temperature and level

of

oxygenation.
Reitz

and Thomas achieved successful myocardial

preservation using simple

immersion of hearts

in cold ICF.
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For the present study,

the convenience of simple storage

in

ICF was also felt to outweigh the unproven benefits of
continuous perfusion,.

Our storage solution was designed to

be cheap and easy to prepare and store.
some of the previous ICF studies
kept very fundamental;

(Table 7)

mannitol
since,

unlike

the solution was

It was not oxygenated and did not

contain other agents such as steroids,
phenoxybenzamine.

Therefore,

fluorocarbons or

The ICF was made hyperosmolar with

and glucose and cooled to four degrees Celsius

as discussed above,

there

is a theoretical basis and

experimental evidence to support the use of both
hyperosmolality and hypothermia

in organ preservation.

No attempt was made to compare the efficacy of our ICF
with that of any other solution or to compare simple storage
to a more complex perfusion system.
each heart as

This study also used

its own control with pre- and post-preservation

assessment as has been recommended(50)
attempted previously(71,74)

but only rarely

with isolated hearts.
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III.

MATERIALS AND METHODS
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III.

A.

MATERIALS AND METHODS

Preparation of the Langendorf Heart:

As discussed above,
preparation
the

(46)

the well-known Langendorf

was used to achieve coronary perfusion of

isolated heart from the arterial circuit of a support

dog.

All experimentation was approved by and conducted under

the supervision of the Animal Care Division.
Six mixed-breed dogs weighing 20kg to 25kg were obtained
from Paradis Animal

Farm

(Brookshire,

VT).

anesthetized with sodium pentobarbitol
North Chicago,
#607,

IL)

The animals were

(Abbot Laboratories,

and maintained on a respirator

Harvard Apparatus Co.,

was provided with heparin

Millis,

MA).

(Elkins-Sinn,

(Harvard

Anticoagulation

Cherry Hill,

NJ).

The heart was exposed through a median sternotomy and the
azygous vein was ligated.
artery,

The venae cavae,

brachiocephalic

and the transverse aortic arch were sequentially

ligated as 500 milliliters of four-degree Celsius standard
operating room cardioplegia

(K+ 25 mEq/L)

the coronary arteries through a cannula
artery.

The

inferior vena cava was

infused into

in the subclavian

incised to decompress the

right ventricle and iced saline was used
hypothermia.

was

for topical

The cardioplegia administration brought about

rapid hypothermic and metabolic arrest and the heart was then
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rapidly excised and placed

in an iced cardioplegia bath.

A

soft latex balloon was connected to a central high pressure
tube and was placed

in the left ventricular cavity following

excision of the mitral valve chordae tendinae.

The balloon

was mounted on a rubber plug which was held securely in place
by a purse-string suture through the mitral valve annulus.
The balloons were pre-stretched and their intrinsic
distensibility checked to ensure that the material

itself

made a negligible contribution to the end-diastolic pressure.
The stiff rubber plug needed to be positioned carefully so
that it would not interfere with the competence of the aortic
valve.

Retrograde aortic flow from the support dog,

allowed direct access to the left ventricle via a
aortic valve,

would have

if

leaky

invalidated both the balloon and

metabolic measurements.

In addition,

the left atrial

remnants were sewn tightly over the rubber plug to ensure
that the left ventricle would contract isovolumetrically as
the balloon was

inflated.

The cannula coming from the balloon emerged from the
rubber plug and was connected to a pressure transducer
(Gould-Statham,

Oxnard,

ventricular pressure
(LV dp/dt)

(LVP).

for measurement of left
Positive left ventricular dp/dt

was obtained by differentiating the LVP signal.

Vents made of 3/16th
Midland,

CA)

MI)

inch Silastic tubing

were placed

(Dow Corning Corp.,

in both ventricles to collect the

Thebesian and coronary sinus

flow.

Epicardial pacing wires

were placed on the surface of the heart and connected to a
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demand pacemaker

(Medtronics,

Minneapolis,

MN)

set to

maintain a minimum heart rate of 100 beats per minute.
cannula was placed

in the aorta and then attached to a

circuit for cross-perfusion from the
support dog

A

(Figure

1).

femoral artery of a

Care was taken to empty all air from

the aorta before beginning perfusion.

The circuit was primed

with 300 milliliters of heparinized blood taken from the
donor dog before excision of the heart.
excise the heart,

prepare

The average time to

it with the balloon and vents,

and

to then connect it to the perfusion circuit was 40 minutes.
The heart was kept bathed in iced saline as much as
technically possible during this preparation.
Following preparation,

the isolated heart was cross-

perfused retrogradely through the aorta with warm,
blood

from the

support dog.

femoral artery of a heparinized,

oxygenated

anesthetized

The coronary artery perfusion pressure was

monitored at the aortic root and maintained at 80 to

100 mmHg

by controlling the flow from the support dog with a large Cclamp.

The drainage

one-liter,
Haven,

CT),

from the two vents was collected in a

water-jacketed chamber

(Yale Glassworks Lab,

New

maintained at thrity-seven degrees Celsius by a

heat exchanger

(Travenol

Labs,

Deerfield Ill.),

to the support dog by the femoral vein.

and returned
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Collection
chamber
Bubble

Heat exchanger
_/V(YfYr(W\_

//v\
Respirator

I
Figure

1:

Circuit used for Parabiotic Perfusion of

the Isolated Heart
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B.

Functional Evaluation

Electrical defibrillation was used

if defibrillation did

not occur spontaneously upon perfusion of the heart
support circuit.

in the

A thirty minute period of stabilization was

allowed before baseline

(pre- twenty-four hour preservation)

data was recorded.
Hemodynamic assessment

The

isovolumetric left

ventricular function was then evaluated by
into the left ventricular balloon

infusion of saline

in five milliliter

increments up to twenty milliliters while measuring LVPD and
LV dp/dt.

Care was taken to prevent air bubbles

entering the
assessment,

intraventricular balloon.

During this period of

the heart was kept suspended well above the

in the collection chamber,
transmural pressure and
pressure tracings.

fluid

since submersion changed the

influenced the left ventricular

The optimal balloon volumes were

determined during the
Figure 2

from

initial preservation experiment.

illustrates that volumes of

five to twenty

milliliters clearly place this heart on the ascending portion
of the

"Starling Curve"

balloon volumes are
studies of

of ventricular

function.

in accordance with those used

isolated canine hearts

(7,70).

These
in other

Mean Pressure Development (mmHg)
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0

20

40

60

80

Balloon Volume (milliliters)

Figure 2: Pressure Development Versus Balloon Volume (Expt. #1)
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Metabolic assessment and determination of water content
Myocardial water content was determined by weight difference
before and after drying biopsies of left ventricular muscle
to constant weight.

Control water content was determined

similarly from samples

from freshly excised hearts.

Arterial

and coronary sinus lactate levels were determined to allow
calculation of lactate extraction:
coronary sinus lactate)/(arterial
(volume %)

[(arterial
lactate)].

was also measured in arterial

lactate Oxygen content

and coronary sinus

blood to allow calculation of oxygen extraction:

[(arterial

oxygen content - coronary sinus oxygen content)/

(arterial

oxygen content)].
ventricular vent

Coronary sinus drainage
(ml/min)

from the right

was multiplied by the arterial-

coronary sinus oxygen difference to yield values
myocardial oxygen consumption.

for
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C.

Preparation of Intracellular Fluid and Twenty-Four Hour
Storage

After obtaining the baseline data,
balloon was emptied and the
arrested,

the intraventricular

isolated heart was again rapidly

this time by flushing approximately lOOcc of

degree Celsius

intracellular-type

fluid

(ICF)

four-

into the

coronary arteries as the blood flow from the support dog was
interrupted.

When the coronary sinus

flow became clear,

the

heart was completely submerged in a one-liter bath of cold,
unoxygenated ICF and placed into a refrigerator.

A

thermistor was placed into the left ventricular chamber via
the LV vent and the temperature was maintained at fourdegrees Celcius throughout the twenty-four hour storage
period.
The ICF was modelled after other intracellular-like
fluids with high osmolarity which have been studied
previously
yielded the

(see Table

1 above).

The recipe

ionic concentrations noted

(Table 3),

in Table 4

as

determined by the clinical chemistry laboratory.
A relatively low concentration of magnesium was used
since,

as noted in previous studies also

(5,65),

magnesium

phosphate crystals tended to form spontaneously when more
magnesium sulfate was added.
detrimental

if

Such a precipitate could be

it were to occur in the coronary vasculature
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Potassium phosphate monobasic
Potassium phosphate dibasic
Potassium chloride
Potassium bicarbonate
Sodium bicarbonate
Magnesium sulfate hydrate
Glucose
Mannitol

Table 3.

2.05
9.70
1.12
2.30
1.25
7.40
20.0
25.0

Recipe for Intracellular Fluid

(qm/L)
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during storage of the hearts.
The

ICF was prepared separately for each experiment.

Although the compounds used are all quite water soluble
each was brought

(82) ,

into solution completely using double-

distilled water before the next compound was added.
compounds were added

in the order listed

The

in Table 3.

Careful

preparation of the ICF in this manner was necessary to
prevent insoluble complex ions,
tribasic,

such as magnesium phosphate

from forming secondary to locally high ion

concentrations.

The ICF was refrigerated at

four-degrees

Celsius overnight and was then filtered through a 22 micron
Whatman filter prior to use.

The ICF in the storage bath was

replaced with fresh solution after eight and again after
sixteen hours of storage.
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D.

Blood Reperfusion

After twenty-four hours of hypothermic storage
ICF bath,

in the

the heart was rewarmed by cross-perfusion from a

support dog and again electrically defibrillated when the
myocardial temperature reached thirty degrees Celsius.
During the

initial period of reperfusion,

effluent was discarded.

The

all coronary venous

function tests performed during

the baseline evaluation were repeated 0.5,
hours

1.0,

2.0,

and 3.0

following restoration of supraventricular rhythm.

During both pre- and post-storage functional
arterial blood gases,

pH,

hematocrit,

evaluations,

the

and arterial blood

pressure of the support dog were monitored and maintained
within normal physiologic range.

No inotropic agents were

used to stimulate the support dog or the
any point.

isolated hearts at
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Potassium
Sodium
Magnesium
Chloride
Phosphate
Bicarbonate
Sulfate
Osmolarity
PH

Table 4.

130
15
3
15
160
30
3

mEq/L
mEq/L
mEq/L
mEq/L
mEq/L
mEq/L
mEq/L

480 mOsm/L
7.2 at 4 C

Composition of Intracellular Fluid
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E.

Handling of Hemodynamic Data

All values of left ventricular pressure development
(LVPD)

and left ventricular positive dp/dt

(LV dp/dt)

extracted from the chart recorder tracings as averages
ten consecutive heartbeats.

were
for

The LVPD for a single cardiac

cycle was calculated as the end-systolic left ventricular
pressure minus the end-diastolic left ventricular pressure.
For each heart,

post-preservation values of LVPD and LV dp/dt

at each time point were expressed as a percentage of baseline
values

for that heart at all

four balloon volumes.

These

normalized values were then averaged to determine the
percent-baseline

function for that heart at each time point.

The overall adequacy of twenty-four hour preservation was
judged by compiling the percent-baseline data
hearts

for all

six

for these hemodynamic parameters.

Diastolic compliance was measured at baseline and at
each reperfusion time point.

Compliance was calculated as

deltaV/deltaP for the end-diastolic pressures as the balloon
was

inflated

from five to twenty milliliters.
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F.

Statistical Analysis

All

results are presented as means plus/minus the

standard error of the mean.

The mean values obtained

following preservation were compared with the baseline data
using the paired Student's T-test with differences considered
significant for values of p<

0.05.

The diastolic compliance curves were

fitted to a

straight line by linear regression using the least-squares
method,

with a coefficient of determination

greater than 0.98

in all cases.

(r-squared)
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IV.

RESULTS
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IV.

A.

RESULTS

Pressure Development and Contractility
Upon blood reperfusion all

six hearts stored for twenty-

four hours were easily electrically defibrillated at a
temperature of thirty degrees Celsius and maintained a
supraventricular rhythm at a rate of 100 to 140 beats per
minute throughout the three-hour period of evaluation.

Five

out of six hearts beat regularly without significant
arrythmias.

The sixth heart had a persistent irregularly

irregular rhythm which interferred with the
assessment using the

functional

intraventricular balloon.

However,

a bolus of lidocaine was given to the support dog,

when

periods of

regular rhythm resulted which facilitated the data
collection.
balloon was

At the end of all six experiments,

the latex

found to conform uniformly to the walls of the

left ventricular chamber.
As noted above,

balloon volumes of five to twenty

mililiters represented a

"preload" that placed the hearts on

the ascending portion of the ventricular function curve.
shown

for the

first experiment,

Figure 2,

at balloon volumes

greater than thirty mililiters ventricular function was
depressed.

As

At much higher volumes the left ventricle was

visibly distended and beating weakly and the perfusion
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pressure at the aortic root was greatly
dp/dt

increased.

The LV

for this heart showed similar response to changes

balloon volume

(Figure

the left ventricle
resulted

3).

Furthermore,

in

overdistension of

following two hours of blood reperfusion,

in significantly poorer subsequent

function.

Table 5 contains the average values of LVPD and LV dp/dt
for the six hearts at a balloon volume of twenty milli¬
liters.

These values put the levels of percent-baseline

function determined
Figures

6,7)

for all

four balloon volumes

into perspective.

(Table

6,

Mean Positive dp/dt (mmHg/sec)

45

Balloon Volume (milliliters)

Figure 3: Positive dp/dt Versus Balloon Volume (Expt. #1)
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Baseline
30 Minutes Reperfusion
60 Minutes Reperfusion
2 Hours Reperfusion
3 Hours Reperfusion
Table 5.

Mean
(mmHq.
89 ±
39 ±
54 ±
72 ±
69 ±

LVPD
N=61
13
5
10
10
12

Mean LV dp/dt
(mmHa. N=6)
2750 ± 537
1788 ± 377
2300 ± 551
4021 ± 1060
4000 ± 1318

Average LVPD and LV dp/dt at a balloon volume of
20 milliliters
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Figure 4

illustrates the chart recorder data obtained

for a representative,

twenty-four hour preserved heart after

three hours of blood reperfusion

(~

28 hours post excision)

at a balloon volume of twenty mililiters.

Figure

5 contains

the ventricular function curves,

LVPD versus balloon volume,

for the same representive heart.

Left ventricular function

was significantly depressed after thirty minutes of
reperfusion and improved progressively with LVPD approaching
this heart's baseline after two hours of reperfusion.

- \--I-<-f—+-)-4-!-1-4—I-1-1-1-+---1-1-

-(-r-I-1-

Support Dog
Pressure

Balloon Pressure
-r-PSP

LVPD

7

-~EDP

Perfusion Pressure
(Measured @ Aortic Root)

VOLUME OF INTRAVENTRICULAR BALLOON

Figure

5:

Ventricular function curves for ..a. representative
isolated heart at baseline and after twenty-four
hours of preservation and blood reperfusion
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The general
reperfusion,
observed

trend of hemodynamic recovery during

demonstrated by the single heart above,

for all

six hearts.

for the six hearts
figures

6 and 7.

was

The composite hemodynamic data

is presented in Table

6 and graphically in

Ventricular pressure development and

positive dp/dt were both significantly depressed thirty
minutes after the start of reperfusion.
dp/dt

Both LVPD and LV

increased during the next several hous and were not

statistically different

from baseline after two hours of

reperfusion.
Heart no.

1,

see Figures 2

and 3,

apparently sustained

an air embolus during the start of perfusion for its baseline
evaluation.

This probably accounts

for the smaller absolute

values of pressure development and LV dp/dt seen for this
heart.

Nonetheless,

this heart also demonstrates the general

trend of hemodynamic recovery upon reperfusion until

it was

injured by overdistension at the two-hour reperfusion time
point.
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Baseline
30 Minutes Reperfusion
60 Minutes Reperfusion
2 Hours Reperfusion
3 Hours Reperfusion

Table 6.

%Baseline LVPD_%Baseline LV dp/dt
100
100
45 ± 10
48 ± 6
64 ± 8
66 ± 12
90 ± 8
122 ± 25
78 ± 6
116 ± 25

Percent-Baseline LVPD and LV dp/dt Averaged for all
Balloon Volumes (N=6)

% Baseline dp/dt
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Figure 6: Recovery of dp/dt Following 24-Hour Preservation (N=6)

% Baseline Left Ventricular Pressure Development
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0

12

3

4

Reperfusion Time (Hours)

Figure 7: Recovery of Left Ventricular Pressure Development (N=6)
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B. Myocardial Compliance and Water Content

(Table 7)

The average diastolic compliance after storage and
thirty minutes of reperfusion decreased considerably to 0.50
ml/mmHg ± 0.04 from a baseline of 1.9 ml/mmHg
(p<0.05).

± 0.26

There was no further change at the subsequent

reperfusion time points with a compliance of 0.52 ml/mmHg ±
0.03 after three hours of reperfusion.

There was a

concomitant increase in gravimetric heart water from a
control value of 78.7
hearts to 82.1 ±

+ 0.03 ml/100 grams for freshly excised

0.4 ml/100 grams for hearts after storage

and three hours of blood reperfusion

(p<0.05).
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Compliance
(ml/minHg)
Baseline
30 Minutes Reperfusion
60 Minutes Reperfusion
2 Hours Reperfusion
3 Hours Reperfusion

1.90
0.50
0.55
0.52
0.52

±
±
±
±
±

0.26
0.04
0.04
0.03
0.03

Water Content
(ml/lOOgm)
78.7

± 0.3

82.1 ± 0.4

Table 7. Diastolic Complicance and Water Content
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C.

Metabolic Function(Tables 8 and 9)
Lactate extraction was seen in all

baseline evaluation.

In contrast,

all

six hearts during the
six hearts were

producing lactate after storage and thirty minutes of
reperfusion.

During the next two hours the six hearts tended

to increase their lactate extraction and three of them gave
evidence of aerobic metabolism by consuming lactate

from the

arterial blood

after

(positive lactate extraction ratios)

three hours of reperfusion.

The average

lactate extraction

ratio at three hours of reperfusion was not statistically
different from baseline.

Likewise,

the myocardial

oxygen

consumption and oxygen extraction ratios during the
reperfusion period did not differ significantly from the
baseline ratios.

In addition,

the support dogs'

artery lactate concentration at baseline

femoral

(1.3 mmol/L 1

0.3)

was not significantly different from the average value during
the reperfusion studies
reperfusion,

(1.5 mmol/L +

1.2 mmol/L +

0.3

0.5 at 30 minutes

at three hours reperfusion).

Baseline
30 Minutes Reperfusion
60 Minutes Reperfusion
2 Hours Reperfusion
3 Hours Reperfusion

Table 8.

0.18
-0.60
-0.32
-0.16
-0.06

+
+
+
+
+

Lactate Extraction Ratios

0.01
0.37
0.09
0.05
0.06

fN=6)
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Oxygen Extraction Ratio
Baseline
30 Minutes Re.
60 Minutes Re.
2 Hours Re.
3 Hours Re.

Table 9.

0.28 ±
0.44 ±
0.34 ±
0.47 ±
0.42 ±

0.06
0.06
0.03
0.09
0.07

Oxygen Consumption
2.8
2.7
2.5
3.5
2.8

+
+
+
+
+

0.6
0.5
0.6
0.7
0.7

Oxygen Extraction Ratios and Myocardial Oxygen
Consumption
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DISCUSSION

Cardiac transplantation for patients with end-stage
cardiac disease

is currently limited by a natural constraint-

—the availability of donor organs.
circulatory support and successful,

Long-term mechanical
socially-acceptable

xenografting are unlikely to supercede the use of human heart
transplantation in the reasonably near future.

Therefore,

the development of a clinically effective method of long-term
cardiac preservation
hearts

is needed

if the shortage of donor

is going to be alleviated.

This study was designed to reevaluate the use of simple
bathing

in cold intracellular fluid

hour cardiac preservation.
storage evaluated cardiac
transplantation.

(ICF)

for twenty-four

Previous studies with simple ICF
function subjectively or by

We used an

isolated,

"non-working" heart

with isovolumetric contraction on an intraventricular
balloon.

Each heart's own post-preservation function was

compared to

its own baseline

(pre-storage)

function.

The

intraventricular balloon allowed precise measurement of the
first derivative of the ventricular pressure curve

(LV dp/dt)

which has been shown to be a good measure of inotropic state
in experimental animals(77).
development

(LVPD)

Left ventricular pressure

was also readily determined with the

intraventricular balloon and demonstrated the

important
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ability of the heart to generate pressure
the diastolic

independently above

"filling pressure" presented by the

inflated

balloon.
The comparison to baseline LV dp/dt and LVPD
Figures

6 and 7)

demonstrates that hyperosmolar ICF afforded

excellent twenty-four hour preservation.

Function was

clearly transiently depressed after storage,
function was regained
reperfusion.

(Table 6,

but adequate

following two hours of blood

Not surprisingly,

improvement in contractile

performance corresponded with a return of metabolic function
towards baseline aerobic metabolism as evidenced by positive
lactate extraction.

The oxygen consumption after storage

also compares well with Levitsky's reported values

following

twenty-four hour preservation with canine plasma(50).

The

steady femoral artery lactate concentrations at baseline and
during reperfusion suggest that the support dogs'
state did not influence the performance of
The mean LV dp/dt of 2750 + 537

metabolic

isolated hearts.

at baseline compares

favorably with previously reported control values of 2960±
180(47)

and 1310+ 109(50)

which were also obtained with the

intraventricular balloon technique.
isolated heart the clinical
difficult to
previous

interpret.

In a non-ejecting,

significance of these values is

However,

they are also similar to

in vivo control values of 1550 ±220,

mmHg/sec(44)

and 1275 mmHg/sec(57).

six preserved hearts

2000± 590

This suggests that the

in this study recovered to a contractile

state that would meet physiologic demands.

The average LVPD
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of 69 itunHg following twenty-four hour storage and three hours
of blood reperfusion also reflects the integrity of
contractile function to within a normal physiologic range.
Following clinical transplantation,

positive

inotropic agents

would be available to further enhance cardiac performance.
The baseline values of myocardial water content agree
very well with previously reported control values(47,42).
The baseline value
ml/mmHg,

for diastolic compliance,

is virtually identical to a previous

value of 1.95±0.30 ml/mmHg(44).
gain and decreased compliance
0.03 ml/mmHg respectively)
studies.

1.90 ±0.26
in vivo control

The post-preservation weight

(82.1 ±0.4 ml/lOOgm and 0.52±

are also in agreement with prior

Laks and Bethencourt reported values of 82.8 ±0.32

ml/lOOgm and 0.65± 0.14 ml/mmHg after twenty-four hour
storage

in modified Krebs solution and three hours of

reperfusion(7).

Kolata et al.

reported a water content of

82.3 ± 0.8 ml/lOOgm after twenty-four hour storage

in a

standard extracellular-type solution(42).
Without further measurements at intermittent time points
it is impossible to correlate the compliance changes with
changes

in water content.

Since compliance remains unchanged

throughout the reperfusion period as ventricular
contractility improves markedly,

decreased compliance does

not appear to prevent good hemodynamic function.

This

confirms the poor relationship between compliance and
hemodynamic function noted by previous
Furthermore,

survival

investigators

(7,80).

following transplantation is not
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predicted well by the weight gain during preservation

(17).

In light of the encouraging results achieved in this
study further laboratory investigation of ICF seems
warranted.

While the

isolated-heart model provides precise

hemodynamic evaluation,
literature,

and has been used extensively in the

it has several

inherent shortcomings.

It

provides no certainty that function of the preserved heart
would be as good in the

"working"

state and in vivo

evaluation with precise hemodynamic measurements would be the
ultimate test of ICF's clinical utility.

In addition,

the

function of the preserved heart was studied only for the
brief three-hour period.

It would be important to confirm

that good hemodynamic function continues.
A short-term orthotopic transplantation study with full
hemodynamic assessment would confirm function of the
"working" heart and would allow clinically meaningful
parameters such as cardiac output and ejection fraction to be
measured.

Subsequently,

a long-term survival

study with

precise hemodynamic assessment initially and at intervals
would confirm hemodynamic function is sustained.

It would

also provide the opportunity to see if edema resolves and
diastolic compliance

increases.

Previous studies have

indicated that myocardial ultrastructure may be damaged
before

functional deterioration is evident by routine

measurements of contractility
ical

(10,53).

Therefore,

histolog¬

studies during ICF preservation would be informative.

In addition,

since high concentrations of potassium are
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extremely irritating to peripheral veins,

further studies of

its effect on the coronary vasculature are needed.

The

effect of ICF on cardiac antigenicity also needs to be
evaluated.
It is unclear why earlier studies with ICF yielded
inconsistent results.
designed to take

The present study was carefully

full advantage of the theoretical benefits

of ICF in an attempt to optimize preservation.

ICF is

felt

to prevent myocardial damage during hypothermic storage and
electromechanical arrest with high extracellular potassium by
maintaining the
Therefore,

integrity of transmembrane

ionic gradients.

during rewarming and reperfusion the cells do not

need to expend ATP to reestablish the normal
and transmembrane voltage potential.

ionic gradients

The ATP which is saved

might then be available to meet other needs of the cell
including actin-myosin interaction.
Measurement of ions,

including calcium,

and ATP levels

during the various stages of preservation and reperfusion
might demonstrate whether or not ICF works

in this manner.

Increasing the magnesium concentration to a true

intracellular

level of about fifteen mEq/L might also improve preservation.
Magnesium occurs
also lost

in the myocardium chelated to ATP and it is

from the cell during ischemia or reperfusion.

magnesium functions,

in part,

of calcium,

is

damage

its

loss

Since

to inhibit mitochondrial uptake

felt to be associated with irreversible

in post-ischemic myocardium

(26,58).

The speed of

rewarming following cold storage might also be

important,

but
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was not investigated
Lastly,

in this study.

the technique of cardiac preservation

investigated—simple

immersion in cold ICF—

is so simple that

transition to clinical practice would be straightforward.
ICF may also prove to be advantageous for short-term
six hours)

Cold

(four to

preservation or as operating-room cardioplegia.
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This

study

confirms

the

SUMMARY

favorable

results

achieved using simple storage of hearts
osmolar

intracellular-type

fluid

that

is

each

it

isolated,
1.

possible

to

use

"non-working" model.

have

in hypothermic,

(ICF).
heart

that

as

It
its

also
own

been

hyper¬

demonstrates
control

in an

We conclude that:

Twenty-four hour preservation by the

simple

technique

of immersion in cold ICF effectively preserves hemodynamic
function
and

as

manifested

"contractility"

without the use of
2.

Hemodynamic

twenty-four

hour

(LV

in

both

pressure development

dp/dt).

This

was

(LVPD)

accomplished

inotropic support;

function

is depressed

preservation

and

initially

subsequently

progressively with blood reperfusion,

after

improves

reaching pre¬

preservation levels after three hours;
3.

Recovery of hemodynamic function occurs despite

decreased diastolic
myocardial
4.

edema;

compliance and the presence

of

and

Recovery of hemodynamic

return of metabolic

function corresponds with the

function towards baseline.

68

VII

BIBLIOGRAPHY

VII.

BIBLIOGRAPHY

Annas, G.J., "No cheers for temporary artificial
hearts", Hastings Center Report, 1985(Oct.): 27.
Angell,

W.W.,

Rikkers,

Organ viability
Cardiovasc.

with

Surg.,

L.,

Dong,

E.,

hypothermia.
1969,

58(5):

Shumway,

J.

N.E.,

Thorac.

619.

Barsamian, E.M., Jacob, S.W., Collins, S.C., Owen,
O.E., The transplantation of dehydrated and supercooled
hearts. Surg. Forum, 1959, 10: 100.
Baumgartner,
E.B.,
Curr.

W.A.,

Shumway,
Probl.

Reitz,

N.E.,

Surg.,

B.A.,

Cardiac

1979,

Oyer,

P.E.,

Stinson,

homotransplantation.

16(9):

2.

Bayliss, C.E.,
(Letter to editor),
Cardiovasc. Surg., 1985, 90: 936.

J.

Thorac.

Bayliss, C.E., Maloney, J.V.,
Shelf-storage of
hearts by manipulation of transmembrane ionic
gradients. Surg. Forum, 1970, 21: 194.
Bethencourt,
compliance
the

dog

D.M.,

Laks,

changes

heart.

J.

H.,

during

24

Thorac.

Importance
hours

of

Cardiovasc.

of

excised

edema

and

preservation

of

Surg.,

81:

1981,

44 0.
Billingham, M.E., Baumgartner, W.A., Watson, D.C.,
Reitz, B.A., Masek, M.A., Raney, A.A., Oyer, P.E.,
Stinson, E.B., Shumway, N.E.,
Distant heart
procurement for human transplantation:
studies.
Circulat., 1980: 62(Suppl.I):
Buckberg,

G.D.,

A

proposed

Cardioplegic

controversy,

Surg.,

77(6):

Buja,

1979,
L.M.,

"solution"
J.

Thorac.

ultrastructural
11.

to

the

Cardiovasc.

803.

Levitsky,

S.,

Ferrans,

V.J.,

Roberts,

W.C., Morrow, A.G., Souther, S.G.,
Acute and chronic
effects of normothermic anoxia on canine hearts: light
and

electron

microscopic

evaluation.

4 3(Suppl.I) :

44.

Burt, J.M.,
preservation

Copeland, J.G.,
for 24 hours.

Surg.,1986,

92:

238.

Circulat.,

Myocardial
J. Thorac.

1971,

function after
Cardiovasc.

70

12.

Caiman, K.C.,
preservation.

Bell, P.R.F., Experimental organ
Brit. J. Surg., 1972, 59(10): 758.

13.

Christopherson, L.
Heart transplants.
Report, 1982, 12: 21.

14.

Cleveland, R.J., Lower, R.R.
Transplantation of canine
cadaver hearts after short-term preservation.
Transplant.,1967, 5: 904.

15.

Collins, G.M., Bravo-Shugarman, M., Terasaki, P.I.,
Kidney preservation for transportation.. The Lancet,
1969, Dec.:1219.

16.

Cooper, D.K., Wicomb, W.N, Rose, A.G., Barnard, C.N.
Orthotopic allotransplantation and autotransplantation
of the baboon heart following 24 hours' storage by a
portable hypothermic perfusion system.
Cryobiol.,
1983, 20: 385.

17.

Copeland, J., Jones, M. , Spragg, R. , Stinson, E.B., In
vitro preservation of canine hearts for 24 to 28 hours
followed by successful orthotopic transplantation.
Ann Surg., 1973, 178: 687.

18.

Emery, R.W., Cork, R.C., Levinson, M.M., Riley, J.E.,
Copeland, J., McAleer, J., Copeland, J.G., The cardiac
donor: a six-year experience.
Ann. Thorac. Surg.,
1986, 41: 356.

19.

Engleman, R.M., Rousow, J.H., Dobbs, W.A.
Fluosol DA,
an artificial blood for total cardiopulmonary bypass.
Ann. Thorac. Surg., 1981, 32: 529.

20.

Evans, R.W., Manninen, D.L., Gersh, B.J., Hart, L.G.,
Rodin, J., The need for and supply of donor hearts for
transplantation.
J. Heart. Transplant., 1984, 4(1):
57.

21.

Evans, R.W., Manninen, D.L., Garrison, Jr., L.P.,
Maier, A.M.,
Donor availability as the primary
determinant of the future of heart transplantation.
J.A.M.A., 1986, 255(4); 1892.

22.

Fallen, E.L., Elliott, W.C., Gorlin, R., Apparatus for
study of ventricular function and metabolism in the
isolated perfused rat heart.
J. Applied Physiol.,
1967, 22: 836.

23.

Feeley, T.W., Mihm, F.G., Downing, T.P., Sadeghi,
A.M., Baumgartner, W.A., Reitz, B.A., Shumway, N.E.,
Hypothermic preservation of the heart and lungs with
Collins' solution: effect on cardiorespiratory

Hastings Center

71

function following heart lung allotransplantation
dogs., Ann. Thorac. Surg., 1986, 41: 301.
24.

25.

Feemster,

J.A.,

pulsatile

the

heart.

canine

Feinberg,

H.,

Engleman,
Kisco,

27.

28.

Transplant.
S.,

and

Futura

Hypothermicfor

preservation

Proc.,

1969,

"Biochemical

in A Textbook

R.M.,

NY:

R.C.:

perfusion

Levitsky,

cardioplegia",

26.

Lillehei,

hyperbaric

of

Levitsky,

1:

of

Cardioplegia.

(editors),

Co.,

of

138.

rationale

Clinical

S.

Publishing

in

Chapt.

1982,

Mt.

10.

Fiskum, S., Lehninger, A.L., The mechanisms and
regulation of mitochondrial calcium transport.
Proc., 1980, 39: 2432.

Fed.

Flores, J., Dibuna, D.R., Beck, C.H., Leaf, A.
The
role of cell swelling in ischemic renal damage and the
protective effect of hypertonic solute.
J. Clin.
Invest., 1972, 51: 118.
Foreman,

J.,

preservation
Thorac.

Pegg,
of

D.E.,

the

Cardiovasc.

Armitage,

heart
Surg.,

at

W.J.,

zero-degrees

1985,

89:

Solutions

for

Celcius.,

J.

867.

29.

Gordon, R.T.,
editor), Ann.

30.

Green, C.J., Pegg, D.E., Mechanism of action of "intra¬
cellular" renal preservation solutions.
World Journal
of Surgery, 1979, 3: 15.

31.

Griepp,

R.B.,

Shumway,
heart.
32.

N.E.,

Guerraty,

A.,

L. ,

R. ,

transplantation

P.,

1974,

following

4:

Dong,

of

6(3):

Warner,

Successful

Thorac.

W.W.,

preservation

Proceed.,

Alivizatos,

J

Angell,

the

24

M.,

hours

Cardiovasc.

E.,

canine

315.
Hess,

orthotopic

Haverich, A., Scott, W.C., Jamieson,
of lung preservation—a review.
J.
1985,

34.

E.B.,

Hypothermic

Lower,

preservation.
531.
33.

Stinson,

Transplant.

Allen,
heart

Myocardial preservation (letter to
Thorac. Surg., 1987, 43(2): 240.

of

Surg.,

S.W.,
Heart

M.,

canine
in

vitro

1981,

82:

Twenty years
Transplant.,

234.

Hearse, D.J., Stewart, D.A., Braimbridge, M.V.,
additive effects of hypothermia and chemical

The

cardioplegia during ischemic cardiac arrest in the
rat.
J. Thorac. Cardiovasc. Surg., 1980, 79: 39.
35.

Hicks,

G.L.,

Arnold,

W.,

Dewall,

cardioplegia

and

myocardial

Surg.,

35:

506.

1983,

R.A.

protection.

Fluorocarbon
Ann.

Thorac.

72

36.

Holdefer, W.F., Edwards, W.S., Ventricular performance
characteristics in a metabolically supported isolated
heart preparation:
a model for evaluating cardiac
storage

methods.,

Surg.

Forum,

1968,

19:

225.

37.

Jynge, P., Hearse, D.J., de Leiris, J., Feuvray, D.,
Braimbridge, M.V., Protection of the ischemic
myocardium. J. Thorac. Cardiovasc. Surg., 1978, 76: 2.

38.

Kanter,
J. T.,

K.R.,

Gott,

Jaffin,

V.L.,

perfluorocarbon
cardioplegia.
39.

40.

42.

43.

T.J.

blood

Circulat.,

and

R.J.,

Superiority

Flaherty,
of

crystalloid

1980,

62(3):

323.

Katz, A.M., A basic scientist reacts to the discussions
of surgery, Proceedings of Cardioplegia Workshop—An
International exchange of Ideals, Deerfield, Ill.,
1980, Travenol Laboratories, 31.
Keeler,

Kohno,

R.,

Swinney,

H.,

J.,

renal

Shiki,
the

K.,

storage

of

Thorac.

Cardiovasc.

rat

Taylor,

R.M.,

preservation.,

Yasutaka,

heart

for

Surg.,

U.,

Uldall,

Brit.

J.

Tokunaga,

K.,

transplantation.

1987,

93:

Kyosola,

K.,

Harjula,

Mattila,

I.,

A.,

Mattila,

Mattila,
P.,

Merikallio,

E.,

hypothermic

K-Fluosol

DA

solutions.

Scand.

Thor.

19:

J.

and

Cold

J.

86.

S.,

after

Aalto-Setalai,

Salmengera,

Cardioplegic

P.R.,

Urol.,

Kolata, R.J., Standeven, J., Codd, J.E., Left
ventricular function and high-energy phosphates
24 hours of hypothermic preservation.
J. Heart
Transplant., 1984, 3(4): 319.

K. ,

44.

Ehrlichman,

Gardner,

over

The problem of
1966, 38: 653.
41.

J.H.,

protection

M.,
with

K/Mg-Fluosol
Cardiovasc.

DA

Surg.,

1985,

267.

Laks,

H.,

Barner,

H.B.,

Hahns,

J.W.,

Standeven,

J.W.,

Jellinek, M., Menz, L.J., Myocardial protection with
intermittent coronary perfusion using cold blood
versus a cardioplegic solution.
Surg. Forum, 1977, 28:
231.
45.

Lam, C.R.,
arrest for
Thorac.

46.

Geoghegan, T., Lepore, A., Induced cardiac
intracardiac surgical procedures.
J.

Surg.,

Langendorf,

1955,

0.,

Lazar,

H.L.,

620.

Untersuchungen

Saugethierherzen.
47.

30:

Pfluegers

Foglia,

R.P.,

an

Uberlebended

Arch.,

1895,

Manganaro,

61:

A.J.,

291.
Buckberg,

73

G.D.,

Detrimental

effects

of

premature

inotropic drugs to discontinue
Surg. Forum, 1978, 29: 276.

use

of

cardiopulmonary

48.

Leaf, A.,
injury.,

49.

Levitsky, S., Mullin, E.D., Sloane, R.E., Ferrans,
V. J.,
Buja,
M. ,
Williams, W.H., Morrow, A.G.,
Effects
of
of

50.

Cell swelling: A factor in
Circulat., 1973, 48: 455.

a hyperosmotic perfusate on
the heart.
Circulat., 1971,

60(5):

53.

Lindbergh,

Thorac.

Cardiovasc.

C.A.,

J.

Lurie,

An

Expt.

K.G.,

apparatus

Med.,

for

1935,

Billingham,

Bristow,

functional

M.R.,

62:

in

on

an

Thorac.

M.E.,

Reitz,

studies

preservation

56.

Melrose,

D.G.,

Elective

cardiac

Lancet,

Dreyer,

1955,

Mendez-Picon,
Long-distance
for

B.,

arrest:
2:

whole

a

newborn.

M.A.,

Ginsberg,

Ultrastructural

and

myocardial

experimental
Cardiovasc.

in

heart

Surg.,

transplant

D.R., Scott, D.F., Downes, G.L., Belzer,
cause of unsuccessful liver and heart
of

1982,

the

Bentall,

ATPase

H.H.,

preliminary

84:

122.
F.O.,

system.

Baker,

J.B.,

communication.

21.

G.J., Goldman, M.H., Wolfgang,
procurement and transportation

transplantation.

Heart

T.C.
of human

Transplant.,

1981,

63.

Miller,
R.J.,
Surg.

L.W.,

Galbraith,

T.,

Codd, J.E., Prolonged
Forum, 1984, 35: 291.

Standeven,
cardiac

J.,

Kolata,

preservation.

Nakae, S., Webb, W.R., Salyer, K.F., Unal, M.O., Cook,
W. A., Dodds, R.P., Williams, G.T.
Extended survival
of the normothermic anoxic heart with metabolic
inhibitors.

59.

Masek,

prolonged

of

Martin,
Primary

1:

58.

culture

J.

hearts

57.

the

model.

The

1970,

409.

B.A.,

preservation: cold sensitivity
Ann. Surg., 1972, 175: 111.
55.

Surg.,

Losman, J.G., Heart xenotransplantation
J. Heart Transplant., 1984, 4: 10.

R. ,

54.

J.

McIntosh,
of the

625.

organs.
52.

heart.

tissue

extended preservation
43(Suppl.I): 124.

Levitsky, S., Williams, W.H., Detmer, D.E.,
C.L., Morrow, A.G., A functional evaluation
preserved

51.

ischemic

bypass.

Noirclerc,
Coutant,

Ann.
M.,

P.,

Thorac.

Duvinage,

Lejeune,

G.,

Surg.,
J.F.,

1967,

Sudan,

Mise

au

3(1):
N.,

point

37.

Tedeschi,
d'un

J.,

procede

74

simple de conservation du poumon assurant une reprise
immediate de fonction apres vingt-quatre heures
d'ischemie.
Acta Chirurgica Belgica, 1972, No. 5.
60.

Offerijns, F.G., Krijnen, H.W.,
rat heart in the frozen state.
289.

The preservation of the
Cryobiol., 1972, 9:

61.

Opie, L.H., Effect of extracellular pH on function and
metabolism of isolated perfused rat hearts.
Am. J.
Physiol. 1965, 209: 1075.

62.

Proctor, E., Matthews, G. Archibald, J., Acute
orthotopic transplantation of hearts stored for 72
hours. Thorax, 1971, 26: 99.

63.

Proctor E., Parker, R., Preservation of isolated
hearts for 72 hours.
Br. Med. J., 1968, 4: 296.

64.

Raithel, K.S., "20 years after first human heart
transplant, 1987 may see 4000 procedures performed
worldwide", J.A.M.A., 1987, 258(21): 3084.

65.

Reitz, B.A., Brody, W.R., Hickey, P.R., Michaelis, L.L.
Protection of the heart for 24 hours with intracellular
(high K+) solution and hypothermia.
Surg. Forum, 1974,
25: 149.

66.

Sacks, S.A., Petritisch, P.H., Kaufman, J.J., Canine
kidney preservation using a new perfusate.
The
Lancet, 1973, 1: 1024.

67.

Schroeder, J.S., Hunt, S., Cardiac transplantation;
update 1987.
J.A.M.A., 1987, 258(21): 3142.

68.

Sewell, D.H., Twomey, J.F., Neill, W.A., Nabseth,
Cleveland, R.J., A protocol for ex vivo cardiac
preservation,
Surg. Forum, 1978, 29: 322.

69.

Stewart, J.R., Gerhart, E.B., Wehr, C.J., Shuman, T.,
Merrill, W., Hammon, Jr., J.W., Bender, Jr., H.W.
Free radical scavengers and myocardial preservation
during transplantation.
Ann Thorac. Surg., 1986, 42:
390.

70.

Suzuki, S., Sasaki, H., Tomita, E., Matsuo, T., Sada,
M., Mizuochi, I., Amemiya, H., Twenty-four hour
preservation of canine hearts by retrograde coronary
sinus perfusion. J. Heart Transplant., 1984, 4(1): 76.

71. Swanson, D.K., Dufek, J.H., Kahn, D.R., Improved
myocardial preservation at four-degrees Celsius.,
Thorac. Surg., 1980, 30(6): 519.

D.C.,

Ann.

75

72.

Thomas, F.T., Schatzki, P.F., Hudson, B.H., Wolf, J.S.,
Successful 24-hour ischemic cardiac preservation using
a new hyperosmolar perfusate.
Surg. Forum, 1975, 26:
253.

73.

Toledo-Pereyra, L.H., Hau, T., Simmons, R.L., Najarian,
J.S., Lung preservation techniques.
Ann. Thorac.
Surg., 1977, 23: 487.

74.

Trunkey, D., Degenhardt, T., Chartrand, C.,
Belzer, F., Preservation of canine hearts.
1970, 6(6): 515.

75.

Tyers, G.F., Williams, E.H., Hughes, H.C., Todd, G.J.,
Effect of perfusate temperature on myocardial
protection from ischemia.
J. Thorac. Cardiovasc.
Surg, 1977, 73(5): 766.

76.

Tyers, G.F., Todd, G.J., Niebauer, I.M., Manley, N.J.,
Waldhausen, J.A., The mechanisim of myocardial damage
following potassium citrate (Melrose) cardioplegia.
Surgery, 1975, 78(1): 45.

77.

Wallace, A.G., Skinner, Jr., N.S., Mitchell, J.H.,
Hemodynamic determinants of the maximal rate of rise
of left ventricular pressure.
Am. J. Physiol., 1963,
205: 30.

78.

Watson, Jr., D.C., Consistent survival after prolonged
donor heart preservation.
Transplant. Proceed., 1977,
9(1): 297.

79.

Watson, Jr., D.C., Gregg, D.L., Rhodes, G.R., Survival
after orthotopic transplantation of hearts preserved
for 48 hours, Surg. Forum, 1976, 27: 255.

80.

Wicomb, W.N., Cooper, D.K., Novitzky, D., Barnard, C.N.
Cardiac transplantation following storage of the donor
heart by a portable hypothermic perfusion system.
Ann. Thorac. Surg., 1984, 37(3): 243.

81.

Wicomb, W.N., Cooper, D.K., Hassoulas, J., Orthotopic
transplantation of the baboon heart after 24 hours
preservation by continuous hypothermic perfusion with
an oxygenated hyperosomolar solution.
J. Thorac.
Cardiovasc. Surg., 1982, 83: 133.

82.

Windholz,

M.,

editor.

of chemicals and drugs.
Merck, 1976.
83.

-,

The Merck Index;
9th edition.

"Survival rates improve,

Pryor, J.,
Cryobiol.,

an encylopedia
Rahway,

age limits fall

NJ:

in

76

Stanford program.",
15.
84 .

Cardiol.

World News,

1985,

April:

-, Xenografts; review of the literature and current
status (Council on Scientific Affairs Report), J.A.M.A.
1985, 254(23): 3353.

■ ale UEE

|

||

3 9002 01012 9964
Au. MEDICAL

YALE MEDICAL LIBRARY
Manuscript Theses

Unpublished theses submitted for the Master's and Doctor's degrees and
deposited in the Yale Medical Library are to be used only with due regard to the
rights of the authors.
Bibliographical references may be noted, but passages
must not be copied without permission of the authors, and without proper credit
being given in subsequent written or published work.

This thesis by
has been
used by the following persons, whose signatures attest their acceptance of the
above restrictions.

NAME AND ADDRESS

DATE

3ir
vnH
ax«r»

